RXO (RXO) Financials

$13.52 -0.47 (-3.38%)

Closing price 03:59 PM Eastern

Extended Trading

$13.78 +0.26 (+1.91%)

As of 07:28 PM Eastern

Annual Income Statements for RXO

This table shows RXO's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	43	150	92	4.00	-290
Consolidated Net Income / (Loss)	43	150	92	4.00	-290
Net Income / (Loss) Continuing Operations	43	150	92	4.00	-290
Total Pre-Tax Income	57	191	119	4.00	-304
Total Operating Income	60	192	123	39	-56
Total Gross Profit	789	1,008	1,172	960	985
Total Revenue	3,357	4,689	4,796	3,927	4,550
Operating Revenue	3,357	4,689	4,796	3,927	4,550
Total Cost of Revenue	2,568	3,681	3,624	2,967	3,565
Operating Cost of Revenue	2,568	3,681	3,624	2,967	3,565
Total Operating Expenses	729	816	1,049	921	1,041
Selling, General & Admin Expense	455	539	640	591	666
Depreciation Expense	76	81	86	67	87
Other Operating Expenses / (Income)	174	192	226	235	202
Restructuring Charge	24	4.00	97	28	86
Total Other Income / (Expense), net	-3.00	-1.00	-4.00	-35	-248
Interest & Investment Income	0.00	0.00	-4.00	-32	-30
Other Income / (Expense), net	-3.00	-1.00	0.00	-3.00	-218
Income Tax Expense	14	41	27	0.00	-14
Basic Earnings per Share	$0.37	$1.30	$0.80	$0.03	($2.17)
Weighted Average Basic Shares Outstanding	115.16M	115.16M	115.34M	116.87M	133.41M
Diluted Earnings per Share	$0.37	$1.30	$0.79	$0.03	($2.17)
Weighted Average Diluted Shares Outstanding	115.16M	115.16M	115.79M	119.46M	133.41M
Weighted Average Basic & Diluted Shares Outstanding	-	-	116.60M	117.09M	163.33M

This table shows RXO's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	15	-5.00	0.00	3.00	-1.00	2.00	-13	-7.00	-243	-27
Consolidated Net Income / (Loss)	13	-4.00	0.00	3.00	-1.00	2.00	-15	-7.00	-243	-25
Net Income / (Loss) Continuing Operations	15	-5.00	0.00	3.00	-1.00	2.00	-13	-7.00	-243	-27
Total Pre-Tax Income	15	-6.00	-3.00	6.00	-3.00	4.00	-21	-8.00	-242	-33
Total Operating Income	15	-1.00	5.00	14	6.00	14	-12	0.00	-20	-24
Total Gross Profit	281	278	251	240	234	235	214	230	231	310
Total Revenue	1,138	1,120	1,010	963	976	978	913	930	1,040	1,667
Operating Revenue	1,138	1,120	1,010	963	976	978	913	930	1,040	1,667
Total Cost of Revenue	857	842	759	723	742	743	699	700	809	1,357
Operating Cost of Revenue	857	842	759	723	742	743	699	700	809	1,357
Total Operating Expenses	266	279	246	226	228	221	226	230	251	334
Selling, General & Admin Expense	158	155	153	144	148	146	145	154	149	218
Depreciation Expense	23	21	18	18	16	15	16	17	21	33
Other Operating Expenses / (Income)	56	59	61	59	59	56	53	50	49	50
Restructuring Charge	29	44	14	5.00	5.00	4.00	12	9.00	32	33
Total Other Income / (Expense), net	2.00	-6.00	-8.00	-8.00	-9.00	-10	-7.00	-8.00	-222	-11
Interest & Investment Income	1.00	-5.00	-8.00	-8.00	-8.00	-8.00	-8.00	-8.00	-6.00	-8.00
Other Income / (Expense), net	1.00	-	0.00	0.00	-1.00	-2.00	1.00	0.00	-216	-3.00
Income Tax Expense	2.00	-2.00	-3.00	3.00	-2.00	2.00	-6.00	-1.00	1.00	-8.00
Basic Earnings per Share	$0.11	($0.03)	$0.00	$0.03	($0.01)	$0.01	($0.13)	($0.06)	($1.81)	($0.17)
Weighted Average Basic Shares Outstanding	115.16M	115.34M	116.60M	116.89M	116.97M	116.87M	117.22M	117.58M	134.10M	133.41M
Diluted Earnings per Share	$0.11	($0.04)	$0.00	$0.03	($0.01)	$0.01	($0.13)	($0.06)	($1.81)	($0.17)
Weighted Average Diluted Shares Outstanding	115.16M	115.79M	119.37M	119.46M	116.97M	119.46M	117.22M	117.58M	134.10M	133.41M
Weighted Average Basic & Diluted Shares Outstanding	116.30M	116.60M	116.92M	116.98M	117.00M	117.09M	117.55M	117.63M	160.79M	163.33M

This table details how cash moves in and out of RXO's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	19	-41	69	-93	30
Net Cash From Operating Activities	25	155	310	89	-12
Net Cash From Continuing Operating Activities	25	155	310	89	-12
Net Income / (Loss) Continuing Operations	43	150	92	4.00	-290
Consolidated Net Income / (Loss)	43	150	92	4.00	-290
Depreciation Expense	76	81	86	67	87
Non-Cash Adjustments To Reconcile Net Income	22	11	38	28	259
Changes in Operating Assets and Liabilities, net	-116	-87	94	-10	-68
Net Cash From Investing Activities	-39	-38	-56	-66	-1,064
Net Cash From Continuing Investing Activities	-39	-38	-56	-66	-1,064
Purchase of Property, Plant & Equipment	-47	-39	-57	-64	-45
Acquisitions	-	-	0.00	0.00	-1,019
Sale of Property, Plant & Equipment	8.00	1.00	1.00	0.00	0.00
Other Investing Activities, net	-	0.00	0.00	-2.00	0.00
Net Cash From Financing Activities	32	-158	-183	-117	1,108
Net Cash From Continuing Financing Activities	32	-158	-183	-117	1,108
Repayment of Debt	0.00	1.00	-10	-177	-221
Repurchase of Common Equity	-	0.00	0.00	-2.00	-30
Issuance of Debt	0.00	0.00	451	76	238
Issuance of Common Equity	-	-	0.00	0.00	1,125
Other Financing Activities, net	32	-159	-624	-14	-4.00
Effect of Exchange Rate Changes	1.00	0.00	-2.00	1.00	-2.00
Cash Interest Paid	-	0.00	0.00	32	27
Cash Income Taxes Paid	2.00	5.00	3.00	27	4.00

This table details how cash moves in and out of RXO's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-25	-89	23	3.00	-20	-99	2.00	-	48	-20
Net Cash From Operating Activities	57	76	42	24	4.00	19	7.00	-5.00	-7.00	-7.00
Net Cash From Continuing Operating Activities	57	76	42	24	4.00	19	7.00	-5.00	-7.00	-7.00
Net Income / (Loss) Continuing Operations	13	-4.00	0.00	3.00	-1.00	2.00	-15	-7.00	-243	-25
Consolidated Net Income / (Loss)	13	-4.00	0.00	3.00	-1.00	2.00	-15	-7.00	-243	-25
Depreciation Expense	23	21	18	18	16	15	16	17	21	33
Non-Cash Adjustments To Reconcile Net Income	4.00	23	6.00	6.00	8.00	8.00	7.00	6.00	223	23
Changes in Operating Assets and Liabilities, net	17	36	18	-3.00	-19	-6.00	-1.00	-21	-8.00	-38
Net Cash From Investing Activities	-14	-18	-12	-16	-19	-19	-11	-11	-1,030	-12
Net Cash From Continuing Investing Activities	-14	-18	-12	-16	-19	-19	-11	-11	-1,030	-12
Purchase of Property, Plant & Equipment	-15	-18	-12	-16	-18	-18	-11	-11	-11	-12
Net Cash From Financing Activities	-68	-145	-8.00	-5.00	-4.00	-100	6.00	16	1,085	1.00
Net Cash From Continuing Financing Activities	-68	-145	-8.00	-5.00	-4.00	-100	6.00	16	1,085	1.00
Repayment of Debt	1.00	-11	-1.00	-1.00	-1.00	-174	-31	-63	-93	-34
Repurchase of Common Equity	-	-	-	-	-	-	-	-	-	-30
Issuance of Debt	-	-	0.00	-	-	76	39	80	84	35
Issuance of Common Equity	-	-	-	-	-	-	-	-	-	30
Effect of Exchange Rate Changes	-	-2.00	1.00	-	-1.00	1.00	0.00	-	-	-2.00
Cash Interest Paid	-	-	0.00	17	1.00	14	1.00	14	-2.00	14
Cash Income Taxes Paid	-	-	6.00	15	4.00	2.00	1.00	1.00	1.00	1.00

This table presents RXO's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Total Assets	2,068	2,031	1,825	3,414
Total Current Assets	1,083	1,029	796	1,339
Cash & Equivalents	29	98	5.00	35
Accounts Receivable	1,010	900	743	1,227
Other Current Assets	44	31	48	77
Plant, Property, & Equipment, net	0.00	119	124	135
Total Noncurrent Assets	985	883	905	1,940
Goodwill	630	630	630	1,123
Intangible Assets	100	79	68	499
Other Noncurrent Operating Assets	255	174	207	318
Total Liabilities & Shareholders' Equity	2,068	2,031	1,825	3,414
Total Liabilities	998	1,444	1,231	1,802
Total Current Liabilities	816	823	682	1,065
Short-Term Debt	0.00	4.00	3.00	17
Accounts Payable	520	501	414	568
Accrued Expenses	248	256	199	373
Other Current Liabilities	48	62	66	107
Total Noncurrent Liabilities	182	621	549	737
Long-Term Debt	0.00	451	356	351
Noncurrent Deferred & Payable Income Tax Liabilities	52	16	7.00	88
Other Noncurrent Operating Liabilities	130	154	186	298
Commitments & Contingencies	-	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,070	587	594	1,612
Total Preferred & Common Equity	1,070	587	594	1,612
Preferred Stock	-	0.00	0.00	0.00
Total Common Equity	1,070	587	594	1,612
Common Stock	-	589	591	1,906
Retained Earnings	-	2.00	6.00	-284
Accumulated Other Comprehensive Income / (Loss)	-2.00	-4.00	-3.00	-10

This table presents RXO's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	2,237	2,018	1,912	1,946	1,799	1,813	3,392
Total Current Assets	1,225	1,029	916	936	770	776	1,255
Cash & Equivalents	187	121	124	104	7.00	7.00	55
Accounts Receivable	1,012	862	743	787	716	725	1,138
Other Current Assets	26	46	49	45	47	44	62
Plant, Property, & Equipment, net	0.00	0.00	116	122	121	118	175
Total Noncurrent Assets	1,012	989	880	888	908	919	1,962
Goodwill	630	630	630	630	630	630	1,027
Intangible Assets	85	76	73	72	65	62	565
Other Noncurrent Operating Assets	297	283	177	186	213	227	370
Total Liabilities & Shareholders' Equity	2,237	2,018	1,912	1,946	1,799	1,813	3,392
Total Liabilities	1,093	1,433	1,323	1,356	1,217	1,234	1,740
Total Current Liabilities	888	820	699	728	674	662	947
Short-Term Debt	5.00	4.00	4.00	3.00	16	16	15
Accounts Payable	547	496	432	448	372	382	572
Accrued Expenses	284	265	210	221	220	197	262
Other Current Liabilities	52	55	53	56	66	67	98
Total Noncurrent Liabilities	205	613	624	628	543	572	793
Long-Term Debt	6.00	451	451	451	351	370	352
Noncurrent Deferred & Payable Income Tax Liabilities	44	16	17	15	1.00	0.00	115
Other Noncurrent Operating Liabilities	155	146	156	162	191	202	326
Commitments & Contingencies	-	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,144	-4.00	589	590	582	579	1,652
Total Preferred & Common Equity	1,144	585	589	590	582	579	1,652
Preferred Stock	-	-	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,144	-4.00	589	590	582	579	1,652
Common Stock	-	-	588	590	594	600	1,916
Retained Earnings	-	-	5.00	4.00	-9.00	-16	-259
Accumulated Other Comprehensive Income / (Loss)	-4.00	-4.00	-4.00	-4.00	-3.00	-5.00	-5.00

This table displays calculated financial ratios and metrics derived from RXO's official financial filings.

Metric	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	39.68%	2.28%	-18.12%	15.86%
EBITDA Growth	0.00%	104.51%	-23.16%	-50.72%	-281.55%
EBIT Growth	0.00%	235.09%	-35.60%	-70.73%	-861.11%
NOPAT Growth	0.00%	233.13%	-36.94%	-58.99%	-200.51%
Net Income Growth	0.00%	248.84%	-38.67%	-95.65%	-7,350.00%
EPS Growth	0.00%	251.35%	-39.23%	-96.20%	-7,333.33%
Operating Cash Flow Growth	0.00%	520.00%	100.00%	-71.29%	-113.48%
Free Cash Flow Firm Growth	0.00%	0.00%	121.58%	-81.78%	-3,060.57%
Invested Capital Growth	0.00%	0.00%	-9.32%	0.42%	105.17%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	-3.49%	17.85%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	6.19%	-12.65%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	50.00%	-16.60%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	132.14%	-211.11%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	300.00%	-10.27%
EPS Q/Q Growth	0.00%	0.00%	0.00%	250.00%	-9.05%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	14.81%	-39.04%	-185.71%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.04%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.85%	-0.97%
Profitability Metrics	-	-	-	-	-
Gross Margin	23.50%	21.50%	24.44%	24.45%	21.65%
EBITDA Margin	3.96%	5.80%	4.36%	2.62%	-4.11%
Operating Margin	1.79%	4.09%	2.56%	0.99%	-1.23%
EBIT Margin	1.70%	4.07%	2.56%	0.92%	-6.02%
Profit (Net Income) Margin	1.28%	3.20%	1.92%	0.10%	-6.37%
Tax Burden Percent	75.44%	78.53%	77.31%	100.00%	95.39%
Interest Burden Percent	100.00%	100.00%	96.75%	11.11%	110.95%
Effective Tax Rate	24.56%	21.47%	22.69%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	28.97%	9.58%	4.12%	-2.71%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	34.39%	7.70%	-5.72%	-75.72%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-0.93%	1.52%	-3.45%	-23.58%
Return on Equity (ROE)	0.00%	28.04%	11.10%	0.68%	-26.29%
Cash Return on Invested Capital (CROIC)	0.00%	-171.03%	19.35%	3.70%	-71.64%
Operating Return on Assets (OROA)	0.00%	9.24%	6.00%	1.87%	-10.46%
Return on Assets (ROA)	0.00%	7.25%	4.49%	0.21%	-11.07%
Return on Common Equity (ROCE)	0.00%	28.04%	11.10%	0.68%	-26.29%
Return on Equity Simple (ROE_SIMPLE)	0.00%	14.02%	15.67%	0.67%	-17.99%
Net Operating Profit after Tax (NOPAT)	45	151	95	39	-39
NOPAT Margin	1.35%	3.22%	1.98%	0.99%	-0.86%
Net Nonoperating Expense Percent (NNEP)	0.00%	-5.42%	1.89%	9.85%	73.01%
Return On Investment Capital (ROIC_SIMPLE)	-	-	9.13%	4.09%	-1.98%
Cost of Revenue to Revenue	76.50%	78.50%	75.56%	75.55%	78.35%
SG&A Expenses to Revenue	13.55%	11.50%	13.34%	15.05%	14.64%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.72%	17.40%	21.87%	23.45%	22.88%
Earnings before Interest and Taxes (EBIT)	57	191	123	36	-274
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	133	272	209	103	-187
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	3.41	4.58	2.38
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.42	0.69	0.84
Price to Earnings (P/E)	0.00	0.00	21.74	680.36	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	4.60%	0.15%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	2.50	3.24	2.14
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.49	0.78	0.92
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	11.28	29.86	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	19.17	85.43	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	24.79	78.86	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	7.60	34.56	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	12.27	87.87	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.00	0.00	0.78	0.60	0.23
Long-Term Debt to Equity	0.00	0.00	0.77	0.60	0.22
Financial Leverage	0.00	-0.03	0.20	0.60	0.31
Leverage Ratio	0.00	1.93	2.47	3.27	2.37
Compound Leverage Factor	0.00	1.93	2.39	0.36	2.63
Debt to Total Capital	0.00%	0.00%	43.67%	37.67%	18.59%
Short-Term Debt to Total Capital	0.00%	0.00%	0.38%	0.31%	0.86%
Long-Term Debt to Total Capital	0.00%	0.00%	43.28%	37.36%	17.73%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	100.00%	56.33%	62.33%	81.41%
Debt to EBITDA	0.00	0.00	2.18	3.49	-1.97
Net Debt to EBITDA	0.00	0.00	1.71	3.44	-1.78
Long-Term Debt to EBITDA	0.00	0.00	2.16	3.46	-1.88
Debt to NOPAT	0.00	0.00	4.78	9.21	-9.39
Net Debt to NOPAT	0.00	0.00	3.75	9.08	-8.49
Long-Term Debt to NOPAT	0.00	0.00	4.74	9.13	-8.95
Altman Z-Score	0.00	0.00	3.52	3.62	2.32
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	0.00	1.33	1.25	1.17	1.26
Quick Ratio	0.00	1.27	1.21	1.10	1.19
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-890	192	35	-1,036
Operating Cash Flow to CapEx	64.10%	407.89%	553.57%	139.06%	-26.67%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.00	2.27	2.34	2.04	1.74
Accounts Receivable Turnover	0.00	4.64	5.02	4.78	4.62
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	32.32	35.14
Accounts Payable Turnover	0.00	7.08	7.10	6.49	7.26
Days Sales Outstanding (DSO)	0.00	78.62	72.68	76.36	79.02
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	51.56	51.42	56.28	50.27
Cash Conversion Cycle (CCC)	0.00	27.06	21.26	20.07	28.75
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	0.00	1,041	944	948	1,945
Invested Capital Turnover	0.00	9.01	4.83	4.15	3.15
Increase / (Decrease) in Invested Capital	0.00	1,041	-97	4.00	997
Enterprise Value (EV)	0.00	0.00	2,357	3,075	4,166
Market Capitalization	0.00	0.00	2,000	2,721	3,833
Book Value per Share	$0.00	$9.29	$5.05	$5.08	$10.03
Tangible Book Value per Share	$0.00	$2.95	($1.05)	($0.89)	($0.06)
Total Capital	0.00	1,070	1,042	953	1,980
Total Debt	0.00	0.00	455	359	368
Total Long-Term Debt	0.00	0.00	451	356	351
Net Debt	0.00	-29	357	354	333
Capital Expenditures (CapEx)	39	38	56	64	45
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	238	112	112	256
Debt-free Net Working Capital (DFNWC)	0.00	267	210	117	291
Net Working Capital (NWC)	0.00	267	206	114	274
Net Nonoperating Expense (NNE)	2.26	0.79	3.09	35	251
Net Nonoperating Obligations (NNO)	0.00	-29	357	354	333
Total Depreciation and Amortization (D&A)	76	81	86	67	87
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	5.08%	2.34%	2.85%	5.63%
Debt-free Net Working Capital to Revenue	0.00%	5.69%	4.38%	2.98%	6.40%
Net Working Capital to Revenue	0.00%	5.69%	4.30%	2.90%	6.02%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.80	$0.03	($2.17)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	115.34M	116.87M	133.41M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.79	$0.03	($2.17)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	115.79M	119.46M	133.41M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	116.60M	117.09M	163.33M
Normalized Net Operating Profit after Tax (NOPAT)	63	154	170	47	21
Normalized NOPAT Margin	1.89%	3.28%	3.55%	1.19%	0.46%
Pre Tax Income Margin	1.70%	4.07%	2.48%	0.10%	-6.68%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	50.00%	-10.34%

This table displays calculated financial ratios and metrics derived from RXO's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.01%	0.00%	-23.02%	-21.45%	-14.24%	-12.68%	-9.60%	-3.43%	6.56%	70.45%
EBITDA Growth	-35.00%	0.00%	-68.06%	-59.49%	-46.15%	35.00%	-78.26%	-46.88%	-1,123.81%	-77.78%
EBIT Growth	-57.89%	0.00%	-90.20%	-75.86%	-68.75%	1,300.00%	-320.00%	-100.00%	-4,820.00%	-325.00%
NOPAT Growth	-60.61%	0.00%	-91.03%	-83.82%	-67.69%	1,100.00%	-340.00%	-100.00%	-433.33%	-340.00%
Net Income Growth	-60.61%	0.00%	-100.00%	-93.18%	-107.69%	150.00%	0.00%	-333.33%	-24,200.00%	-1,350.00%
EPS Growth	-62.07%	0.00%	-100.00%	-92.11%	-109.09%	125.00%	0.00%	-300.00%	-18,000.00%	-1,800.00%
Operating Cash Flow Growth	0.00%	111.11%	-59.22%	-67.57%	-92.98%	-75.00%	-83.33%	-120.83%	-275.00%	-136.84%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	103.37%	0.00%	96.57%	95.84%	-3,323.60%	-33,893.33%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	-2.89%	0.42%	2.50%	4.13%	108.94%	105.17%
Revenue Q/Q Growth	-7.18%	-1.58%	-9.82%	-4.65%	1.35%	0.20%	-6.65%	1.86%	11.83%	60.29%
EBITDA Q/Q Growth	-50.63%	-48.72%	15.00%	39.13%	-34.38%	28.57%	-80.00%	240.00%	-1,364.71%	102.79%
EBIT Q/Q Growth	-72.41%	-106.25%	600.00%	180.00%	-64.29%	140.00%	-210.00%	100.00%	0.00%	88.56%
NOPAT Q/Q Growth	-69.95%	-105.38%	600.00%	100.00%	-40.00%	66.67%	-220.00%	100.00%	0.00%	-20.00%
Net Income Q/Q Growth	-70.45%	-130.77%	100.00%	0.00%	-133.33%	300.00%	-850.00%	53.33%	-3,371.43%	89.71%
EPS Q/Q Growth	-71.05%	-136.36%	100.00%	0.00%	-133.33%	200.00%	-1,400.00%	53.85%	-2,916.67%	90.61%
Operating Cash Flow Q/Q Growth	-22.97%	33.33%	-44.74%	-42.86%	-83.33%	375.00%	-63.16%	-171.43%	-40.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	100.00%	0.00%	0.27%	103.53%	-90.68%	-1,146.67%	-21.02%	-2,631.58%	2.33%
Invested Capital Q/Q Growth	0.00%	-2.48%	-2.65%	0.11%	2.17%	0.85%	-0.63%	1.70%	105.01%	-0.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	24.69%	24.82%	24.85%	24.92%	23.98%	24.03%	23.44%	24.73%	22.21%	18.60%
EBITDA Margin	3.43%	1.79%	2.28%	3.32%	2.15%	2.76%	0.55%	1.83%	-20.67%	0.36%
Operating Margin	1.32%	-0.09%	0.50%	1.45%	0.61%	1.43%	-1.31%	0.00%	-1.92%	-1.44%
EBIT Margin	1.41%	-0.09%	0.50%	1.45%	0.51%	1.23%	-1.20%	0.00%	-22.69%	-1.62%
Profit (Net Income) Margin	1.14%	-0.36%	0.00%	0.31%	-0.10%	0.20%	-1.64%	-0.75%	-23.37%	-1.50%
Tax Burden Percent	86.67%	66.67%	0.00%	50.00%	33.33%	50.00%	71.43%	87.50%	100.41%	75.76%
Interest Burden Percent	93.75%	600.00%	-60.00%	42.86%	-60.00%	33.33%	190.91%	0.00%	102.54%	122.22%
Effective Tax Rate	13.33%	0.00%	0.00%	50.00%	0.00%	50.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-0.32%	3.39%	6.69%	1.84%	2.97%	-3.79%	0.00%	-3.58%	-3.17%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-1.24%	2.63%	4.27%	-4.14%	1.56%	-4.82%	-1.97%	-72.76%	-5.56%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-0.76%	-607.05%	2.40%	-0.42%	0.94%	-10.69%	-1.20%	-21.49%	-1.73%
Return on Equity (ROE)	0.00%	-1.07%	-603.66%	9.08%	1.42%	3.91%	-14.48%	-1.20%	-25.06%	-4.90%
Cash Return on Invested Capital (CROIC)	0.00%	20.35%	0.00%	0.00%	0.00%	3.70%	-0.82%	-3.45%	-71.39%	-71.64%
Operating Return on Assets (OROA)	0.00%	-0.21%	1.10%	3.22%	1.00%	2.50%	-2.42%	0.00%	-32.83%	-2.81%
Return on Assets (ROA)	0.00%	-0.84%	0.00%	0.69%	-0.20%	0.42%	-3.30%	-1.53%	-33.80%	-2.60%
Return on Common Equity (ROCE)	0.00%	-1.07%	-603.66%	9.08%	1.42%	3.91%	-14.48%	-1.20%	-25.06%	-4.90%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	9.06%	2.04%	-0.34%	0.00%	-1.89%	-3.63%	-15.92%	0.00%
Net Operating Profit after Tax (NOPAT)	13	-0.70	3.50	7.00	4.20	7.00	-8.40	0.00	-14	-17
NOPAT Margin	1.14%	-0.06%	0.35%	0.73%	0.43%	0.72%	-0.92%	0.00%	-1.35%	-1.01%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.92%	0.76%	2.42%	5.98%	1.41%	1.03%	1.97%	69.18%	2.39%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.07%	-	-	-	0.73%	-	-	-	-0.85%
Cost of Revenue to Revenue	75.31%	75.18%	75.15%	75.08%	76.02%	75.97%	76.56%	75.27%	77.79%	81.40%
SG&A Expenses to Revenue	13.88%	13.84%	15.15%	14.95%	15.16%	14.93%	15.88%	16.56%	14.33%	13.08%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.37%	24.91%	24.36%	23.47%	23.36%	22.60%	24.75%	24.73%	24.13%	20.04%
Earnings before Interest and Taxes (EBIT)	16	-1.00	5.00	14	5.00	12	-11	0.00	-236	-27
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	39	20	23	32	21	27	5.00	17	-215	6.00
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	3.41	0.00	4.50	3.91	4.58	4.40	5.31	1.99	2.38
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	54.89	0.00
Price to Revenue (P/Rev)	0.00	0.42	0.51	0.63	0.57	0.69	0.67	0.81	0.85	0.84
Price to Earnings (P/E)	0.00	21.74	43.21	203.90	0.00	680.36	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	4.60%	2.31%	0.49%	0.00%	0.15%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	2.50	2.86	3.24	2.83	3.24	3.10	3.60	1.84	2.14
Enterprise Value to Revenue (EV/Rev)	0.00	0.49	0.58	0.70	0.65	0.78	0.76	0.91	0.93	0.92
Enterprise Value to EBITDA (EV/EBITDA)	0.00	11.28	16.40	26.39	27.40	29.86	34.34	49.33	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	19.17	34.08	90.35	110.75	85.43	145.94	575.48	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	24.79	41.79	90.35	158.22	78.86	189.53	616.59	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	7.60	10.54	14.98	18.21	34.56	54.05	138.12	257.54	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	87.87	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	0.78	-113.75	0.77	0.77	0.60	0.63	0.67	0.22	0.23
Long-Term Debt to Equity	0.01	0.77	-112.75	0.77	0.76	0.60	0.60	0.64	0.21	0.22
Financial Leverage	-0.15	0.61	-230.75	0.56	0.10	0.60	2.22	0.61	0.30	0.31
Leverage Ratio	1.96	2.47	-504.50	3.25	2.41	3.27	6.60	3.19	2.38	2.37
Compound Leverage Factor	1.83	14.84	302.70	1.39	-1.45	1.09	12.61	0.00	2.44	2.90
Debt to Total Capital	0.95%	43.67%	100.89%	43.58%	43.49%	37.67%	38.67%	40.00%	18.18%	18.59%
Short-Term Debt to Total Capital	0.43%	0.38%	0.89%	0.38%	0.29%	0.31%	1.69%	1.66%	0.74%	0.86%
Long-Term Debt to Total Capital	0.52%	43.28%	100.00%	43.20%	43.20%	37.36%	36.99%	38.34%	17.43%	17.73%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.05%	56.33%	-0.89%	56.42%	56.51%	62.33%	61.33%	60.00%	81.82%	81.41%
Debt to EBITDA	0.00	2.18	2.84	4.03	4.68	3.49	4.32	5.51	-2.21	-1.97
Net Debt to EBITDA	0.00	1.71	2.09	2.93	3.61	3.44	4.24	5.41	-1.88	-1.78
Long-Term Debt to EBITDA	0.00	2.16	2.82	3.99	4.65	3.46	4.13	5.29	-2.12	-1.88
Debt to NOPAT	0.00	4.78	7.25	13.79	27.02	9.21	23.83	68.93	-29.13	-9.39
Net Debt to NOPAT	0.00	3.75	5.32	10.03	20.83	9.08	23.38	67.68	-24.76	-8.49
Long-Term Debt to NOPAT	0.00	4.74	7.18	13.67	26.85	9.13	22.79	66.07	-27.94	-8.95
Altman Z-Score	0.00	3.31	3.32	3.58	3.25	3.58	3.43	3.65	2.05	2.56
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.38	1.25	1.25	1.31	1.29	1.17	1.14	1.17	1.33	1.26
Quick Ratio	1.35	1.21	1.20	1.24	1.22	1.10	1.07	1.11	1.26	1.19
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-955	0.00	-916	-913	32	3.00	-31	-38	-1,038	-1,014
Operating Cash Flow to CapEx	380.00%	422.22%	350.00%	150.00%	22.22%	105.56%	63.64%	-45.45%	-63.64%	-58.33%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	2.34	2.23	2.21	1.95	2.04	2.01	2.04	1.45	1.74
Accounts Receivable Turnover	0.00	5.02	5.21	5.69	4.52	4.78	4.85	5.17	4.01	4.62
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	36.47	0.00	32.32	0.00	32.45	26.00	35.14
Accounts Payable Turnover	0.00	7.10	6.78	7.36	6.16	6.49	6.70	7.09	5.79	7.26
Days Sales Outstanding (DSO)	0.00	72.68	70.01	64.10	80.69	76.36	75.19	70.56	90.99	79.02
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	51.42	53.85	49.57	59.23	56.28	54.49	51.51	63.08	50.27
Cash Conversion Cycle (CCC)	0.00	21.26	16.16	14.53	21.46	20.07	20.70	19.05	27.91	28.75
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	968	944	919	920	940	948	942	958	1,964	1,945
Invested Capital Turnover	0.00	5.08	9.78	9.20	4.27	4.15	4.12	4.04	2.66	3.15
Increase / (Decrease) in Invested Capital	968	0.00	919	920	-28	4.00	23	38	1,024	997
Enterprise Value (EV)	0.00	2,357	2,624	2,982	2,658	3,075	2,919	3,453	3,606	4,166
Market Capitalization	0.00	2,000	2,290	2,651	2,308	2,721	2,559	3,074	3,294	3,833
Book Value per Share	$9.93	$5.05	($0.03)	$5.04	$5.04	$5.08	$4.97	$4.93	$14.04	$10.03
Tangible Book Value per Share	$3.73	($1.05)	($6.09)	($0.98)	($0.96)	($0.89)	($0.96)	($0.96)	$0.51	($0.06)
Total Capital	1,155	1,042	451	1,044	1,044	953	949	965	2,019	1,980
Total Debt	11	455	455	455	454	359	367	386	367	368
Total Long-Term Debt	6.00	451	451	451	451	356	351	370	352	351
Net Debt	-176	357	334	331	350	354	360	379	312	333
Capital Expenditures (CapEx)	15	18	12	16	18	18	11	11	11	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	155	112	92	97	107	112	105	123	268	256
Debt-free Net Working Capital (DFNWC)	342	210	213	221	211	117	112	130	323	291
Net Working Capital (NWC)	337	206	209	217	208	114	96	114	308	274
Net Nonoperating Expense (NNE)	0.00	3.30	3.50	4.00	5.20	5.00	6.60	7.00	229	8.20
Net Nonoperating Obligations (NNO)	-176	357	923	331	350	354	360	379	312	333
Total Depreciation and Amortization (D&A)	23	21	18	18	16	15	16	17	21	33
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	2.34%	2.05%	2.29%	2.63%	2.85%	2.74%	3.24%	6.94%	5.63%
Debt-free Net Working Capital to Revenue	0.00%	4.38%	4.74%	5.22%	5.19%	2.98%	2.92%	3.42%	8.37%	6.40%
Net Working Capital to Revenue	0.00%	4.30%	4.65%	5.13%	5.11%	2.90%	2.51%	3.00%	7.98%	6.02%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.11	($0.03)	$0.00	$0.03	($0.01)	$0.01	($0.13)	($0.06)	($1.81)	($0.17)
Adjusted Weighted Average Basic Shares Outstanding	115M	115.34M	116.60M	116.89M	116.97M	116.87M	117.22M	117.58M	134.10M	133.41M
Adjusted Diluted Earnings per Share	$0.11	($0.04)	$0.00	$0.03	($0.01)	$0.01	($0.13)	($0.06)	($1.81)	($0.17)
Adjusted Weighted Average Diluted Shares Outstanding	115M	115.79M	119.37M	119.46M	116.97M	119.46M	117.22M	117.58M	134.10M	133.41M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	116.30M	116.60M	116.92M	116.98M	117.00M	117.09M	117.55M	117.63M	160.79M	163.33M
Normalized Net Operating Profit after Tax (NOPAT)	38	30	13	9.50	7.70	9.00	0.00	6.30	8.40	6.30
Normalized NOPAT Margin	3.35%	2.69%	1.32%	0.99%	0.79%	0.92%	0.00%	0.68%	0.81%	0.38%
Pre Tax Income Margin	1.32%	-0.54%	-0.30%	0.62%	-0.31%	0.41%	-2.30%	-0.86%	-23.27%	-1.98%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	16.67%	-100.00%	50.00%	0.00%	0.00%	0.00%	-10.34%

Frequently Asked Questions About RXO's Financials

When does RXO's financial year end?

According to the most recent income statement we have on file, RXO's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has RXO's net income changed over the last 4 years?

RXO's net income appears to be on an upward trend, with a most recent value of -$290 million in 2024, falling from $43 million in 2020. The previous period was $4 million in 2023.

What is RXO's operating income?

RXO's total operating income in 2024 was -$56 million, based on the following breakdown:

Total Gross Profit: $985 million
Total Operating Expenses: $1.04 billion

How has RXO revenue changed over the last 4 years?

Over the last 4 years, RXO's total revenue changed from $3.36 billion in 2020 to $4.55 billion in 2024, a change of 35.5%.

How much debt does RXO have?

RXO's total liabilities were at $1.80 billion at the end of 2024, a 46.4% increase from 2023, and a 80.6% increase since 2021.

How much cash does RXO have?

In the past 3 years, RXO's cash and equivalents has ranged from $5 million in 2023 to $98 million in 2022, and is currently $35 million as of their latest financial filing in 2024.

How has RXO's book value per share changed over the last 4 years?

Over the last 4 years, RXO's book value per share changed from 0.00 in 2020 to 10.03 in 2024, a change of 1,002.6%.

Remove Ads

Related Companies

This page (NYSE:RXO) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RXO (RXO) Financials

Frequently Asked Questions About RXO's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

RXO (RXO) Financials

Annual Income Statements for RXO

Quarterly Income Statements for RXO

Annual Cash Flow Statements for RXO

Quarterly Cash Flow Statements for RXO

Annual Balance Sheets for RXO

Quarterly Balance Sheets for RXO

Annual Metrics and Ratios for RXO

Quarterly Metrics and Ratios for RXO

Frequently Asked Questions About RXO's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools